Items where Author is "Birtle, Alison"

Article

Huddart, Robert, Hafeez, Shaista, Griffin, Clare, Choudhury, Ananya, Foroudi, Farshad, Syndikus, Isabel, Hindson, Benjamin, Webster, Amanda, McNair, Helen et al (2025) Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial. European Urology, 87 (1). pp. 60-70. ISSN 0302-2838

Rescigno, Pasquale, Porta, Nuria, Finneran, Laura, Riisnaes, Ruth, Figueiredo, Ines, Carreira, Suzanne, Flohr, Penny, Miranda, Susana, Bertan, Claudia et al (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205 . p. 114103. ISSN 0959-8049

Syndikus, Isabel, Griffin, Clare, Philipps, Lara, Tree, Alison, Khoo, Vincent, Birtle, Alison, Choudhury, Anaya and Ferguson, Catherine (2023) 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016). Journal of Clinical Oncology, 41 (6). p. 304. ISSN 0732-183X

Brocklehurst, Andrew, Varughese, Mohini and Birtle, Alison (2022) Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology. Seminars in Radiation Oncology, 33 (1). pp. 62-69. ISSN 10534296

Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Tran, Ben, Jeffery, Mark, Mazhar, Danish, Huddart, Robert A et al (2021) P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediateand poor-risk metastatic germ cell tumours (GCTs). Journal of Clinical Oncology, 39 (6).

Other

Birtle, Alison, Jones, Robert, Cafferty, Fay H., Biscombe, Katie and Hall, Emma (2024) Reply to P. de Boissieu et al. American Society of Clinical Oncology (ASCO).